SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-160469
Filing Date
2021-05-13
Accepted
2021-05-13 16:02:57
Documents
42
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d169721d10q.htm   iXBRL 10-Q 996263
2 EX-31.1 d169721dex311.htm EX-31.1 10264
3 EX-31.2 d169721dex312.htm EX-31.2 10534
4 EX-32.1 d169721dex321.htm EX-32.1 5045
  Complete submission text file 0001193125-21-160469.txt   3703291

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cbay-20210331.xsd EX-101.SCH 22611
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20210331_cal.xml EX-101.CAL 24141
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20210331_def.xml EX-101.DEF 112280
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20210331_lab.xml EX-101.LAB 211346
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20210331_pre.xml EX-101.PRE 159694
10 EXTRACTED XBRL INSTANCE DOCUMENT d169721d10q_htm.xml XML 611864
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 21919509
SIC: 2834 Pharmaceutical Preparations